The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an injection is more effective than the current care of steroid tablets and ...

Learn about side effects, uses, dosage, and more for Fasenra (benralizumab), a prescription drug that treats eosinophilic asthma in adults and some children.

Fasenra is a monoclonal antibody which works by targeting eosinophils (a type of white blood cell), to reduce lung inflammation. Fasenra is approved for the treatment of severe eosinophilic asthma ...

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting eosinophilic inflammation, it reduces steroid use by 30% and lowers ...

Benralizumab, a monoclonal antibody, is already used for the long-term management of eosinophilic asthma, with studies still evaluating the effect of long-term management in eosinophilic COPD.

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial. The Lancet Respiratory Medicine , 2024 ...

Injection for asthma and COPD attacks shows a 30% reduction in the need for further treatment, outperforming steroid tablets. About Careers Internship MedBlog Contact us English (US) ...

The injection targets eosinophilic exacerbations, caused by high eosinophil levels, which lead to wheezing, coughing and chest tightness. These exacerbations make up 30% of COPD flare-ups and nearly ...

An injection given during some asthma and COPD attacks is more effective ... Eosinophilic exacerbations make up to 30% of COPD ... Benralizamab is a monoclonal antibody which targets ...

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European ...

To explore the effect of a rat anti-mouse CC-chemokine receptor-3 (CCR3) monoclonal antibody (CCR3 mAb) on airway eosinophilia and mucus overproduction in asthmatic mice. An asthma model was ...